Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 INC Research Names Early Phase Oncology VP | Contract Pharma
Breaking News, Promotions & Moves

INC Research Names Early Phase Oncology VP

Akers-Smith brings 10 years of CRO experience

Susan Akers-Smith has been appointed vice president of Early Phase Oncology Development at INC Research. Ms. Akers-Smith will provide global leadership for advanced clinical development solutions to meet the early phase needs of the company’s oncology customers, with the goal of driving growth in this key area of the business.
 
Ms. Akers-Smith has served in various management and operational positions at INC Research in the oncology therapeutic business unit, and managed complex early phase oncology trials. She has more than a decade of management experience in the CRO industry focused on early-phase oncology development, with therapeutic experience including a broad range of study designs and tumor types.
 
“We are thrilled to recognize Susan’s individual efforts, creativity and performance through this well-deserved promotion,” said Nicholas Kenny, Ph.D., executive vice president and general manager, Global Oncology and Hematology, INC Research. “We always strive to combine operational efficiency with the latest advancements in medical and regulatory knowledge to conduct cancer trials of the highest quality. Susan epitomizes the leadership traits necessary for this role and we look forward to leveraging her experience to further support the growing early phase oncology research needs of our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters